Related Experiment Videos
Successful treatment of aspergillus brain abscess in a child with acute lymphoblastic leukemia
Abstract:
Cerebral aspergillosis carries a high mortality in immunocompromised patients. However, favorable outcome can be achieved by the prolonged use of antifungal agents and the maintenance of adequate drug levels. The authors report a 2-year-old girl who developed an aspergillus brain abscess during treatment for acute lymphoblastic leukemia. Predisposing factors for the fungal infection and details of the antifungal therapy are described. Prolonged treatment with AmBisome and 5-flucytosine successfully eradicated the lesion, but the girl's antileukemic therapy was compromised due to the infection. She developed a central nervous system and bone marrow relapse 9 and 15 months, respectively, after the initial presentation. The report emphasizes the need for further consideration of effective, long-term antifungal prophylaxis and a careful balance between aggressive treatment for severe infection and antileukemic therapy.
Insights
Effective antifungal treatment can improve outcomes for immunocompromised children with cerebral aspergillosis. Balancing infection treatment with leukemia therapy is crucial for long-term survival.
Area of Science:
- Medical Mycology
- Pediatric Oncology
- Infectious Diseases
Background:
- Cerebral aspergillosis is a severe complication in immunocompromised patients, particularly those undergoing cancer treatment.
- Maintaining adequate antifungal drug levels is key to achieving favorable outcomes.
Observation:
- A 2-year-old girl with acute lymphoblastic leukemia developed an aspergillus brain abscess.
- Predisposing factors and specific antifungal therapy (AmBisome and 5-flucytosine) were detailed.
- The antifungal treatment successfully eradicated the brain lesion.
Findings:
- The successful eradication of the aspergillus brain abscess was achieved through prolonged AmBisome and 5-flucytosine therapy.
- However, the antifungal treatment compromised the patient's acute lymphoblastic leukemia therapy.
- The patient experienced a central nervous system and bone marrow relapse post-infection treatment.
Implications:
- This case highlights the critical need for effective, long-term antifungal prophylaxis in immunocompromised children.
- A careful balance between aggressive infection management and essential antileukemic therapy is necessary.
- Further research into optimizing combined treatment strategies for invasive fungal infections in pediatric cancer patients is warranted.